Morgan Stanley Quarterly Profit Falls 10% 
 

Second-quarter profit fell 10% at Morgan Stanley, the last of the big U.S. banks to report earnings in a mixed quarter where trading slowed and Main Street banks carried the day.

 
Blackstone's Earnings Fall as Private-Equity Portfolio Cools 
 

Blackstone's second-quarter earnings fell from a year earlier as the value of its private-equity portfolio appreciated less.

 
Honeywell Posts Higher Profit 
 

Honeywell reported stronger demand and higher organic sales in its commercial aerospace, defense, process automation and business-technologies businesses.

 
UnitedHealth Lifts Profit Targets on Stronger Sales 
 

UnitedHealth Group raised its 2019 earnings targets after reporting a strong first half of the year, driven by broader sales growth in premiums, products and services.

 
Vodafone's Liberty Global Deal Gets EU Nod 
 

The European Union's antitrust authority has cleared Vodafone Group's acquisition of some assets from Liberty Global, paving the way for a multibillion-euro deal that is set to reshape the European telecoms market.

 
Digital Banking Startup Overcomes Setbacks to Raise $170 Million 
 

A digital bank with operations across Europe which recently launched in the U.S. has raised another $170 million in its latest funding round, pushing its valuation to $3.5 billion.

 
iHeartMedia Returns to Public Markets 
 

The nation's largest radio broadcaster begins trading about 2 1/2 months after emerging from bankruptcy.

 
Qualcomm Hit by Second Antitrust Fine in Europe 
 

The EU is imposing a $272 million fine on Qualcomm, its second penalty on the chip maker in 18 months, and its latest move targeting top U.S. tech companies for breaching antitrust rules.

 
Paint Maker PPG Posts Lower Sales on Weak Industrial Demand 
 

PPG said weak demand from industrial clients is hurting sales, challenging the company's decision to keep its paint and coatings businesses joined together.

 
Novartis Sets $700 Million Provision to Settle Bribery Allegations 
 

Swiss drugmaker Novartis set aside $700 million to settle a long-running lawsuit alleging it treated U.S. doctors to lavish dinners and other events in return for boosting prescriptions.

(END) Dow Jones Newswires

July 18, 2019 11:15 ET (15:15 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.